FDA Device Intelligence
Home2BREATHE TECHNOLOGIES LTD › RESPeRATE

RESPeRATE

2BREATHE TECHNOLOGIES LTD · Model ULTRA · UDI-DI 07290017402000

HCC
1
510(k) clearances
59
Adverse events (1 deaths)
4
Recalls
108
Facilities

Description

RESPeRATE lowers blood pressure by relaxing constricted blood vessels which cause high blood pressure. RESPeRATE does so by harnessing the therapeutic power of slow-paced breathing with prolonged exhalation in a way that is virtually impossible to achieve on your own. All you have to do is breathe along with RESPeRATE’s guiding tones.

Recalls

DateFirmReason
2023-12-11RONAN MEDICAL LLCNeurofeedback systems removed due to missing design and development documentation and devices may not perform as intended.
2017-07-07Ondamed IncThe firm was marketing the Ondamed System in the US without marketing clearance. As a corrective action, the firm revised its device design to comply with regulations. The firm has
2015-10-01Powers Medical Devices, LLCPAL unit has undergone significant technological changes since the previous 510(k) and labeling is not consistent with the cleared indications of the 510(k).
2012-11-15EEG InfoEEG Info, Inc. is recalling the EEG Neuroamp device because they have identified a potential risk associated with the mislabeling of certain devices.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.